Cargando…

The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease

BACKGROUND: In the last decade, incomplete Kawasaki disease (KD), intravenous immunoglobulin (IVIG) non-response and coronary artery abnormalities (CAA) have experienced the increasing trends in China. In addition, the enhancement of pediatricians’ awareness may also raise the diagnostic rate of inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Samadli, Sama, Liu, Fei Fei, Mammadov, Goshgar, Wang, Jing Jing, Liu, Hui Hui, Wu, Yang Fang, Luo, Huang Huang, Wu, Yue, Chen, Wei Xia, Zhang, Dong Dong, Wei, Wei, Hu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668082/
https://www.ncbi.nlm.nih.gov/pubmed/31366406
http://dx.doi.org/10.1186/s12969-019-0352-3
_version_ 1783440152167710720
author Samadli, Sama
Liu, Fei Fei
Mammadov, Goshgar
Wang, Jing Jing
Liu, Hui Hui
Wu, Yang Fang
Luo, Huang Huang
Wu, Yue
Chen, Wei Xia
Zhang, Dong Dong
Wei, Wei
Hu, Peng
author_facet Samadli, Sama
Liu, Fei Fei
Mammadov, Goshgar
Wang, Jing Jing
Liu, Hui Hui
Wu, Yang Fang
Luo, Huang Huang
Wu, Yue
Chen, Wei Xia
Zhang, Dong Dong
Wei, Wei
Hu, Peng
author_sort Samadli, Sama
collection PubMed
description BACKGROUND: In the last decade, incomplete Kawasaki disease (KD), intravenous immunoglobulin (IVIG) non-response and coronary artery abnormalities (CAA) have experienced the increasing trends in China. In addition, the enhancement of pediatricians’ awareness may also raise the diagnostic rate of incomplete KD and stimulate more aggressive initial therapy in the acute episode of KD. Given this background, we hypothesize that the time option of IVIG treatment should be in parallel with peak time of systemic inflammation; either earlier or later IVIG treatment may affect the clinical classification, therapeutic responsiveness and CAA occurrence in KD patients. Therefore, the major objective of the present study is to identify whether the time option of IVIG treatment could be associated with the clinical classification, therapeutic responsiveness and CAA occurrence in the acute episode of KD. MATERIALS AND METHODS: A total of 153 children with KD were recruited between July 2015 and May 2018. All patients received the standard therapy of KD, including a single infusion of IVIG (2 g/kg) and aspirin (30–50 mg/kg/d). Blood samples were collected from all subjects within 24 h pre-IVIG treatment, respectively. Echocardiography was performed during the period from 2 days to 14 days after IVIG treatment. RESULTS: (1) The clinical classification presented no significant heterogenicity among different treatment time (x(2) = 1.59, p > 0.05) (2) Eleven KD patients resisted to IVIG treatment and 7 of them (63.60%) received the initial IVIG dose on day 5 and 6. (3) The distribution of CAA onset was subjected to a significant difference according to timing option of IVIG treatment (x(2) = 11.94, p < 0.05). CONCLUSIONS: The time option of IVIG treatment is associated with therapeutic responsiveness and CAA but not with clinical classification in the acute episode of KD.
format Online
Article
Text
id pubmed-6668082
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66680822019-08-05 The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease Samadli, Sama Liu, Fei Fei Mammadov, Goshgar Wang, Jing Jing Liu, Hui Hui Wu, Yang Fang Luo, Huang Huang Wu, Yue Chen, Wei Xia Zhang, Dong Dong Wei, Wei Hu, Peng Pediatr Rheumatol Online J Research Article BACKGROUND: In the last decade, incomplete Kawasaki disease (KD), intravenous immunoglobulin (IVIG) non-response and coronary artery abnormalities (CAA) have experienced the increasing trends in China. In addition, the enhancement of pediatricians’ awareness may also raise the diagnostic rate of incomplete KD and stimulate more aggressive initial therapy in the acute episode of KD. Given this background, we hypothesize that the time option of IVIG treatment should be in parallel with peak time of systemic inflammation; either earlier or later IVIG treatment may affect the clinical classification, therapeutic responsiveness and CAA occurrence in KD patients. Therefore, the major objective of the present study is to identify whether the time option of IVIG treatment could be associated with the clinical classification, therapeutic responsiveness and CAA occurrence in the acute episode of KD. MATERIALS AND METHODS: A total of 153 children with KD were recruited between July 2015 and May 2018. All patients received the standard therapy of KD, including a single infusion of IVIG (2 g/kg) and aspirin (30–50 mg/kg/d). Blood samples were collected from all subjects within 24 h pre-IVIG treatment, respectively. Echocardiography was performed during the period from 2 days to 14 days after IVIG treatment. RESULTS: (1) The clinical classification presented no significant heterogenicity among different treatment time (x(2) = 1.59, p > 0.05) (2) Eleven KD patients resisted to IVIG treatment and 7 of them (63.60%) received the initial IVIG dose on day 5 and 6. (3) The distribution of CAA onset was subjected to a significant difference according to timing option of IVIG treatment (x(2) = 11.94, p < 0.05). CONCLUSIONS: The time option of IVIG treatment is associated with therapeutic responsiveness and CAA but not with clinical classification in the acute episode of KD. BioMed Central 2019-07-31 /pmc/articles/PMC6668082/ /pubmed/31366406 http://dx.doi.org/10.1186/s12969-019-0352-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Samadli, Sama
Liu, Fei Fei
Mammadov, Goshgar
Wang, Jing Jing
Liu, Hui Hui
Wu, Yang Fang
Luo, Huang Huang
Wu, Yue
Chen, Wei Xia
Zhang, Dong Dong
Wei, Wei
Hu, Peng
The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
title The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
title_full The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
title_fullStr The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
title_full_unstemmed The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
title_short The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
title_sort time option of ivig treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of kawasaki disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668082/
https://www.ncbi.nlm.nih.gov/pubmed/31366406
http://dx.doi.org/10.1186/s12969-019-0352-3
work_keys_str_mv AT samadlisama thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT liufeifei thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT mammadovgoshgar thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT wangjingjing thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT liuhuihui thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT wuyangfang thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT luohuanghuang thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT wuyue thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT chenweixia thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT zhangdongdong thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT weiwei thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT hupeng thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT samadlisama timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT liufeifei timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT mammadovgoshgar timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT wangjingjing timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT liuhuihui timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT wuyangfang timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT luohuanghuang timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT wuyue timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT chenweixia timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT zhangdongdong timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT weiwei timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease
AT hupeng timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease